Oral Prednisone is the Standard Route of Administration for Muscular Dystrophy
Prednisone should be given orally (as tablets or liquid) rather than by injection for chronic treatment of Duchenne muscular dystrophy. Injectable corticosteroids are not part of standard care for DMD and are not mentioned in any treatment guidelines or protocols 1.
Route of Administration
The FDA-approved formulation of prednisone for chronic use is oral (tablets), designed to be readily absorbed from the gastrointestinal tract 2. All clinical trials and guidelines for DMD exclusively use oral administration:
- Daily oral prednisone: 0.75 mg/kg/day is the first-line regimen 1, 3
- Weekend-only oral prednisone: 5 mg/kg given each Friday and Saturday 1
- Intermittent oral prednisone: 0.75 mg/kg/day for 10 days alternating with 10-20 days off 1
Why Oral Administration is Preferred
Practical considerations:
- Oral prednisone is readily absorbed from the GI tract and achieves therapeutic levels effectively 2
- Chronic treatment requires daily or near-daily dosing for years, making injections impractical and painful
- The medication should be given in the morning (prior to 9 AM) to minimize adrenal suppression, which is easily accomplished with oral dosing 2
Evidence base: All efficacy data demonstrating improved muscle strength, prolonged ambulation, delayed scoliosis, and improved pulmonary function come from oral administration 4, 3, 5. There is no evidence supporting injectable corticosteroids for chronic DMD management.
Dosing Recommendations
For children with DMD, the standard approach is 1, 3:
- Starting dose: Prednisone 0.75 mg/kg/day orally (or deflazacort 0.9 mg/kg/day)
- Timing: Administer in the morning before 9 AM with food or milk to reduce gastric irritation 2
- Dose adjustment: Increase incrementally with growth up to maximum of 30-40 mg/day (at approximately 40 kg body weight) 1
- Duration: Continue even when non-ambulatory for benefits on scoliosis, pulmonary function, and cardiac function 1
Alternative Oral Regimens
If side effects (weight gain, behavioral changes) become problematic with daily dosing 1:
- Weekend-only regimen: 5 mg/kg each Friday and Saturday - equally effective at 12 months with potentially less weight gain 1, 3
- Intermittent regimen: 0.75 mg/kg/day for 10 days on, 10-20 days off - less effective but better tolerated 1
- Dose reduction: Decrease by 25-33% and reassess in 1 month 1
Common Pitfall to Avoid
Do not confuse acute high-dose IV methylprednisolone (used for multiple sclerosis relapses at 200 mg/day for 1 week 2) with chronic oral prednisone therapy for DMD. These are entirely different treatment paradigms for different conditions. DMD requires long-term oral maintenance therapy, not pulse IV therapy.